Pictet Asset Management LTD Has Cut By $6.52 Million Its Public Storage (PSA) Position; Pieris Pharmaceuticals (PIRS) Shorts Lowered By 4.48%

September 17, 2017 - By Vivian Currie

Pictet Asset Management Ltd decreased Public Storage (PSA) stake by 25.42% reported in 2016Q4 SEC filing. Pictet Asset Management Ltd sold 29,250 shares as Public Storage (PSA)’s stock declined 5.00%. The Pictet Asset Management Ltd holds 85,797 shares with $19.18 million value, down from 115,047 last quarter. Public Storage now has $37.26 billion valuation. The stock increased 0.75% or $1.59 on September 15, reaching $214.15. About 1.03M shares traded or 27.21% up from the average. Public Storage (NYSE:PSA) has declined 14.14% since September 17, 2016 and is downtrending. It has underperformed by 30.84% the S&P500.

Pieris Pharmaceuticals Incorporated (NASDAQ:PIRS) had a decrease of 4.48% in short interest. PIRS’s SI was 2.42 million shares in September as released by FINRA. Its down 4.48% from 2.54 million shares previously. With 366,200 avg volume, 7 days are for Pieris Pharmaceuticals Incorporated (NASDAQ:PIRS)’s short sellers to cover PIRS’s short positions. The SI to Pieris Pharmaceuticals Incorporated’s float is 7.48%. The stock decreased 0.19% or $0.01 on September 15, reaching $5.39. About 211,297 shares traded. Pieris Pharmaceuticals Inc (NASDAQ:PIRS) has risen 128.81% since September 17, 2016 and is uptrending. It has outperformed by 112.11% the S&P500.

Among 16 analysts covering Public Storage (NYSE:PSA), 2 have Buy rating, 3 Sell and 11 Hold. Therefore 13% are positive. Public Storage had 51 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Monday, October 31. The stock of Public Storage (NYSE:PSA) earned “Buy” rating by Argus Research on Wednesday, January 27. On Monday, September 11 the stock rating was initiated by BMO Capital Markets with “Sell”. The firm has “Neutral” rating given on Thursday, July 23 by Robert W. Baird. The stock has “Neutral” rating by Goldman Sachs on Monday, January 4. On Thursday, March 23 the stock rating was maintained by BMO Capital Markets with “Hold”. The stock of Public Storage (NYSE:PSA) has “Underweight” rating given on Friday, July 15 by KeyBanc Capital Markets. The stock has “Buy” rating by Zacks on Wednesday, September 2. On Wednesday, August 10 the stock rating was maintained by Jefferies with “Hold”. As per Monday, November 16, the company rating was maintained by Argus Research.

Pictet Asset Management Ltd increased Edwards Lifesciences Corp (NYSE:EW) stake by 38,528 shares to 242,352 valued at $22.71 million in 2016Q4. It also upped Scotts Miracle Gro Co (NYSE:SMG) stake by 16,893 shares and now owns 152,712 shares. Verifone Sys Inc (NYSE:PAY) was raised too.

Analysts await Public Storage (NYSE:PSA) to report earnings on October, 25. They expect $2.61 EPS, up 3.98% or $0.10 from last year’s $2.51 per share. PSA’s profit will be $454.11 million for 20.51 P/E if the $2.61 EPS becomes a reality. After $2.31 actual EPS reported by Public Storage for the previous quarter, Wall Street now forecasts 12.99% EPS growth.

Among 6 analysts covering Pieris Pharmaceuticals (NASDAQ:PIRS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Pieris Pharmaceuticals had 11 analyst reports since July 22, 2015 according to SRatingsIntel. Roth Capital initiated the stock with “Buy” rating in Wednesday, July 22 report. Roth Capital maintained the stock with “Buy” rating in Thursday, August 13 report. The firm earned “Market Outperform” rating on Wednesday, August 12 by JMP Securities. The stock has “Buy” rating by H.C. Wainwright on Tuesday, May 30. The firm has “Buy” rating given on Thursday, August 17 by Oppenheimer. The stock of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) has “Buy” rating given on Friday, August 11 by H.C. Wainwright. TH Capital initiated the stock with “Buy” rating in Wednesday, July 22 report. The rating was reinitiated by Roth Capital with “Buy” on Friday, August 5. The firm has “Outperform” rating by Oppenheimer given on Tuesday, July 28. JMP Securities maintained Pieris Pharmaceuticals Inc (NASDAQ:PIRS) on Wednesday, March 9 with “Market Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com